Agree. My last sentence meant they are complimentary.
We have a few scandals coming in the pharma /health space, opioids is one blowing up right now, next will be chemo (and the exploitation of cancer), vaccines (and the long term silent damage to the immune system, and for some very unlucky ones, pretty immediate damage (settled often outside of court and without any transparency)... big medical associations are being questioned (see recent debate on ketogenic diet, which is an extremely powerful diet to heal many things), FDA being overruled by Trump latest's exec order. The system is being found out.
IF you don't see the writing is on the wall, and pharma is going to undergo huge change and major restructuring, you're not seeing the next 5-15 years clearly.
This is why this is the big long. Disruptive and about to replace about 500 other medicines for about 20 different diseases... Opportunity of a lifetime. And it's also the right thing to do.
- Forums
- ASX - By Stock
- CGB
- Folks, I predict we are about to see much more interest in the QBL/MCL connection. The MCL subsidiar
Folks, I predict we are about to see much more interest in the QBL/MCL connection. The MCL subsidiar, page-7
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online